Wealth Architects, LLC Lineage Cell Therapeutics, Inc. Transaction History

Wealth Architects, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$1.12 - $1.61 $18,032 - $25,921	-16,100 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.21 - $2.48 $19,481 - $39,928	16,100 New	16,100 $25,000
Q3 2021 Nov 09, 2021	SELL	$2.26 - $2.86 $39,549 - $50,050	-17,500 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$2.17 - $3.0 $40,145 - $55,500	-18,500 Reduced 51.39%	17,500 $50,000
Q1 2021 Apr 29, 2021	BUY	$1.77 - $3.1 $31,860 - $55,800	18,000 Added 100.0%	36,000 $85,000
Q4 2020 Jan 28, 2021	BUY	$0.95 - $1.83 $17,100 - $32,940	18,000 New	18,000 $32,000

132

92.6M

80.9K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $117M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Architects, LLC with notifications on news.